
Company valuation, historical trends, and peer comparisons.
According to Arrowhead Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.29B. This represents a change of 0.84% compared to the average of 9.21B of the last 4 quarters.
The mean historical Enterprise Value of Arrowhead Pharmaceuticals, Inc. over the last ten years is 2.96B. The current 9.29B Enterprise Value has changed 213.59% with respect to the historical average. Over the past ten years (40 quarters), ARWR's Enterprise Value was at its highest in in the June 2026 quarter at 12.50B. The Enterprise Value was at its lowest in in the December 2016 quarter at 10.77M.
Average
2.96B
Median
3.11B
Minimum
294.43M
Maximum
6.32B
Discovering the peaks and valleys of Arrowhead Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 436.25%
Maximum Annual Enterprise Value = 6.32B
Minimum Annual Increase = -45.27%
Minimum Annual Enterprise Value = 294.43M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 4.75B | 54.85% |
| 2024 | 3.07B | -2.28% |
| 2023 | 3.14B | -9.17% |
| 2022 | 3.46B | -45.27% |
| 2021 | 6.32B | 49.90% |
| 2020 | 4.21B | 73.93% |
| 2019 | 2.42B | 53.47% |
| 2018 | 1.58B | 436.25% |
| 2017 | 294.43M | -19.47% |
| 2016 | 365.62M | 46.29% |
The current Enterprise Value of Arrowhead Pharmaceuticals, Inc. (ARWR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.65B
5-year avg
4.15B
10-year avg
2.96B
Arrowhead Pharmaceuticals, Inc.’s Enterprise Value is less than Alnylam Pharmaceuticals, Inc. (20.98B), greater than Silence Therapeutics plc (861.64M), greater than Ionis Pharmaceuticals, Inc. (9.02B), greater than Wave Life Sciences Ltd. (536.26M), greater than ProQR Therapeutics N.V. (69.23M), greater than Arcturus Therapeutics Holdings Inc. (117.20M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 20.98B | $21.47B | |
| 861.64M | $933.58M | |
| 9.02B | $6.95B | |
| 536.26M | $690.30M | |
| 69.23M | $194.04M | |
| 117.20M | $285.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arrowhead Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arrowhead Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arrowhead Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Arrowhead Pharmaceuticals, Inc. (ARWR)?
What is the 3-year average Enterprise Value for Arrowhead Pharmaceuticals, Inc. (ARWR)?
What is the 5-year average Enterprise Value for Arrowhead Pharmaceuticals, Inc. (ARWR)?
How does the current Enterprise Value for Arrowhead Pharmaceuticals, Inc. (ARWR) compare to its historical average?